Floatz logo

Levulan® Kerastick®

Actinic Keratosis

Medical Dermatology SpecialistsPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Actinic Keratosis cohort.

Asset / SponsorPhaseRating
INGENOL MEBUTATE
University of California, San Francisco
Phase 4BB
FLUOROURACILUM
Sol-Gel Technologies, Ltd.
Phase 3BB
Efudex
Sol-Gel Technologies, Ltd.
Phase 3BB
Liposomal T4N5 Lotion
National Cancer Institute (NCI)
Phase 2B
5-ala
Brigham and Women's Hospital
Phase 2CCC
5-ala
Brigham and Women's Hospital
N/AD

Same molecule, other indications

Levulan® Kerastick® is also rated in:

skin carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
skin cancerDormant
CCC
Indicative ·
48 / 100
View asset →
UV-induced skin damage, susceptibility toDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →